Text Size:
Color Theme:

Company Information

Revenue, expenses and profitability over five years.

Income Statement

ASTEC LIFESCIENCES LTD.

NSE Code
ASTECEQ
BSE Code
533138
ISIN
INE563J01010
Industry
Agro Chemicals/Pesticides
Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Table can be scrolled horizontally on smaller screens.

Five-year standalone Income Statement for the selected company
ParticularsMar 26Mar 25Mar 24Mar 23Mar 22
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
INCOME
Revenue From Operations [Net]445.72378.15457.70628.17676.57
Other Operating Revenues2.433.160.480.000.00
Total Operating Revenues448.15381.30458.18628.17676.57
Other Income4.995.565.5813.0410.46
Total Revenue453.13386.86463.76641.20687.03
EXPENSES
Cost Of Materials Consumed270.45248.86318.82460.83444.82
Changes In Inventories Of FG,WIP And Stock-In Trade27.9648.080.46-59.59-58.00
Employee Benefit Expenses62.9161.1061.7452.2650.31
Finance Costs34.5736.7125.2420.749.09
Depreciation And Amortisation Expenses44.9943.7736.3133.7134.42
Other Expenses91.3389.4683.0698.4085.36
Total Expenses532.21527.98525.64606.35565.99
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-79.08-141.12-61.8834.85121.04
Exceptional Items-2.090.000.000.000.00
Profit/Loss Before Tax-81.17-141.12-61.8834.85121.04
Tax Expenses-Continued Operations
Current Tax0.000.000.000.0028.61
Deferred Tax-0.16-6.31-14.899.332.61
Total Tax Expenses-0.16-6.31-14.899.3331.22
Profit/Loss After Tax And Before ExtraOrdinary Items-81.01-134.81-46.9925.5289.82
Profit/Loss From Continuing Operations-81.01-134.81-46.9925.5289.82
Profit/Loss For The Period-81.01-134.81-46.9925.5289.82
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)-37.83-68.74-23.9613.0245.85
Diluted EPS (Rs.)-37.83-68.74-23.9613.0245.83
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend0.000.002.942.942.94
Equity Dividend Rate (%)0.000.000.0015.0015.00

Source: Financial statements as reported by the company.